Quince Therapeutics, Inc.
QNCX
$1.61
$0.010.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.60M | 40.78M | 47.85M | 59.45M | 67.82M |
| Total Receivables | 916.00K | 882.00K | 995.00K | 964.00K | 971.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 758.00K | 986.00K | 1.41M | 725.00K | 910.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 556.00K | 1.38M | 1.47M | 2.30M | 735.00K |
| Total Current Assets | 33.83M | 44.04M | 51.72M | 63.44M | 70.44M |
|
|
|||||
| Total Current Assets | 33.83M | 44.04M | 51.72M | 63.44M | 70.44M |
| Net Property, Plant & Equipment | 941.00K | 813.00K | 767.00K | 800.00K | 810.00K |
| Long-term Investments | -- | -- | -- | -- | 17.25M |
| Goodwill | -- | -- | -- | -- | 17.25M |
| Total Other Intangibles | 62.37M | 60.05M | 464.00K | 450.00K | 62.25M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.88M | 9.51M | 73.49M | 70.06M | 8.47M |
| Total Assets | 107.09M | 114.48M | 126.52M | 134.83M | 159.29M |
|
|
|||||
| Total Accounts Payable | 3.01M | 2.90M | 1.62M | 2.41M | 2.07M |
| Total Accrued Expenses | 5.01M | 3.97M | 3.50M | 2.54M | 2.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 102.00K | 96.00K | 101.00K | 94.00K | 93.00K |
| Total Finance Division Other Current Liabilities | 233.00K | 308.00K | 198.00K | 5.28M | 5.05M |
| Total Other Current Liabilities | 233.00K | 308.00K | 198.00K | 5.28M | 5.05M |
| Total Current Liabilities | 8.36M | 7.28M | 5.43M | 10.32M | 9.84M |
|
|
|||||
| Total Current Liabilities | 8.36M | 7.28M | 5.43M | 10.32M | 9.84M |
| Long-Term Debt | 15.27M | 14.32M | 14.90M | 13.83M | 13.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 383.00K | 394.00K | 450.00K | 453.00K | 480.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 64.50M | 62.34M | 60.81M | 63.25M | 61.28M |
| Total Liabilities | 88.51M | 84.33M | 81.59M | 87.86M | 85.12M |
|
|
|||||
| Common Stock & APIC | 408.13M | 406.65M | 405.53M | 404.40M | 403.15M |
| Retained Earnings | -391.50M | -376.47M | -364.01M | -358.52M | -330.79M |
| Treasury Stock & Other | 1.96M | -35.00K | 3.42M | 1.09M | 1.83M |
| Total Common Equity | 18.58M | 30.15M | 44.93M | 46.97M | 74.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.58M | 30.15M | 44.93M | 46.97M | 74.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.58M | 30.15M | 44.93M | 46.97M | 74.18M |
|
|
|||||